Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × plitidepsin × Clear all

Phase

Status

Sponsor Class

INDUSTRY 8 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Neoplasm Metastasis 1 Liposarcoma 1

Interventions

Cyclophosphamide 1736 Radiotherapy 1594 Cisplatin 1525 Carboplatin 1295 Gemcitabine 1203 Paclitaxel 1101 Bevacizumab 1059 Docetaxel 1044 pembrolizumab 1022 Capecitabine 979 Oxaliplatin 976 Fluorouracil 914 Dexamethasone 828 Rituximab 778 Nivolumab 773 Magnetic Resonance Spectroscopy 728 Etoposide 705 Doxorubicin 697 Irinotecan 661 Radiosurgery 660 Drug Therapy 659 Cytarabine 635 fludarabine 617 Leucovorin 577 Lenalidomide 525 fludarabine phosphate 479 Radiation 467 Temozolomide 464 Filgrastim 462 Cetuximab 457

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01876043 2021-01-25

APLIPO

Institut Bergonié

Phase 2 Terminated

24 enrolled 10 charts

Liposarcoma, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡